Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FX4HK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,258
Award facts
- Contract value 100% obligated
- $14,258.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,258.45 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen injections on November 4, 2025, with completion scheduled for November 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply an extensive range of medications, vaccines, and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio demonstrates extensive experience delivering specialized pharmaceuticals across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing. This award for Cosentyx, an immunosuppressant used to treat inflammatory conditions, reflects the company's ongoing role in supplying specialty medications essential to military medical operations and federal healthcare initiatives.
Quick answers
Who was awarded contract SPE2DB26FX4HK?
SPE2DB26FX4HK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FX4HK worth?
The government has obligated $14,258 on SPE2DB26FX4HK.
Is contract SPE2DB26FX4HK an order under another contract?
Yes. SPE2DB26FX4HK is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4HK competed?
The extent of competition for SPE2DB26FX4HK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award